Find comprehensive information on short stature diagnosis, including clinical documentation, ICD-10 codes (E34.3, R62.52), SNOMED CT concepts, and growth hormone deficiency evaluation. This resource covers diagnostic criteria, medical coding guidelines, and best practices for healthcare professionals documenting short stature in children and adults. Learn about growth charts, bone age assessment, and other relevant clinical findings for accurate diagnosis and treatment of short stature.
Also known as
Short stature
Short stature, not otherwise specified.
Short stature, unspecified
Short stature, unspecified as to cause.
Achondroplasia
A genetic disorder causing disproportionately short stature.
Disorders of calcium metabolism
Calcium disorders can sometimes contribute to growth problems.
Follow this step-by-step guide to choose the correct ICD-10 code.
Disproportionate short stature?
When to use each related code
| Description |
|---|
| Short stature |
| Constitutional growth delay |
| Growth hormone deficiency |
Coding short stature without specifying underlying cause (e.g., achondroplasia, growth hormone deficiency) leads to inaccurate data and potential denials. ICD-10 specificity is crucial for proper reimbursement.
Miscoding constitutional growth delay as a growth hormone deficiency can lead to unnecessary testing, treatment, and inflated costs. Accurate documentation is essential for proper coding (R62.5 vs. E23.0).
Insufficient documentation of growth velocity and parental heights can hinder accurate diagnosis coding and impact medical necessity reviews for growth hormone therapy. Complete clinical data is crucial.
Patient presents with concerns regarding short stature. Family history was reviewed including parental heights and growth patterns. Patient's height and weight were measured and plotted on a growth chart, demonstrating height below the third percentile for age and sex. The patient's bone age was assessed via radiographic examination of the left wrist and hand. Current height velocity was calculated and compared to age-appropriate standards. Assessment includes evaluation for proportionate vs disproportionate short stature, considering potential underlying causes such as growth hormone deficiency, constitutional growth delay, genetic syndromes (Turner syndrome, Down syndrome, Noonan syndrome), hypothyroidism, chronic illnesses (celiac disease, inflammatory bowel disease, chronic kidney disease), and skeletal dysplasias (achondroplasia). Differential diagnosis includes familial short stature. Further investigations may include laboratory tests such as complete blood count, comprehensive metabolic panel, thyroid function tests, insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) levels. Genetic testing may be considered based on clinical findings. Treatment plan will be determined based on the underlying etiology of the short stature and may include growth hormone therapy, if indicated. Patient and family were educated about the diagnosis, diagnostic process, and potential treatment options. Follow-up appointment scheduled to discuss results of investigations and formulate a definitive management plan. ICD-10 code R62.52 Short stature, child unspecified will be utilized, subject to change pending further diagnostic clarification. CPT codes for evaluation and management, radiographic imaging, and laboratory testing will be billed accordingly.